Latest News and Press Releases
Want to stay updated on the latest news?
-
LAS VEGAS, Jan. 20, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that the United States District Court for the District of Nevada has approved the following announcement of a proposed class...
-
NEW YORK, Jan. 19, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against AlloVir, Inc. (“AlloVir” or the “Company”) (NASDAQ: ALVR). The class action,...
-
NEW YORK, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Amtech Systems, Inc. (“Amtech” or the “Company”) (NASDAQ: ASYS). Such investors are...
-
NEW YORK, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Iovance Biotherapeutics, Inc. (“Iovance” or the “Company”) (NASDAQ: IOVA). Such investors...
-
NEW YORK, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Arbor Realty Trust, Inc. (“Arbor” or the “Company”) (NYSE: ABR). Such investors are...
-
NEW YORK, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Hywin Holdings Ltd. (“Hywin” or the “Company”) (NASDAQ: HYW). Such investors are advised...
-
NEW YORK, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Brooge Energy Limited (“Brooge” or the “Company”) (NASDAQ: BROG). Such investors are...
-
NEW YORK, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Milestone Pharmaceuticals Inc. (“Milestone” or the “Company”) (NASDAQ: MIST). Such...
-
NEW YORK, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of NeoGenomics, Inc. (“NeoGenomics” or the “Company”) (NASDAQ: NEO). Such investors are...
-
NEW YORK, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Envoy Medical, Inc. (“Envoy” or the “Company”) (NASDAQ: COCH). Such investors are advised...